Research predicts rise in IBD in developing world

f98aa236-bfa9-41f7-abeb-9d7e0996d4c5articleimage.jpg

24 Oct 2017 --- For the last century, inflammatory bowel disease (IBD) has been a challenge for patients and the medical community in the Western world. Now, research published in The Lancet by Dr. Gilaad Kaplan shows that countries outside the Western world may now be facing the same pattern of increasing IBD rates.

“Over the past 100 years, the incidence of IBD in western countries has climbed and then plateaued,” says Kaplan, an associate professor at the Cumming School of Medicine. “Our research shows that countries outside the western world now appear to be in the first stage of this sequence.”

IBD affects over 0.3 percent of the population in North America and Europe, according to the University of Calgary press release. “IBD is a modern disease, growing in prevalence in North America, Europe and Australia since the 1950s,” says Kaplan. “As countries in Asia, South America and the Middle East have become industrialized, IBD has emerged, and its incidence is rising dramatically. At the turn of the 21st century, it became a global disease.”

Done in collaboration with Siew Ng, Ph.D., at the Chinese University of Hong Kong, the research brings together data from all population-based studies reporting on the incidence or prevalence of IBD since 1990. “As newly industrialized countries become more westernized, we can clearly see that the incidence of IBD is also rapidly rising,” says Ng.

As IBD becomes a global problem, Kaplan and Ng are hopeful that a coordinated solution to prevent and treat IBD around the world could be possible.

“Future research should focus on identifying environmental risk factors observed during the early stages of industrialization,” says Ng. Kaplan agrees: “Research into environmental intervention that helps to prevent IBD should be prioritized.”

Kaplan presented the findings at the World Congress of Gastroenterology on October 16 in Orlando, Florida, US. “The increasing prevalence of IBD will challenge clinicians and health policy-makers,” says Kaplan. “Globally, we need to prepare our clinical infrastructure and personnel to manage this complex and costly disease.”

Related Articles

Nutrition & Health News

Energetic growth: Energy boosters add pep to the nutritional space’s step

11 Dec 2017 --- Busy schedules can cause consumers to go through an “energy crisis” – prompting their desire to reach for products that might offer some support to their energy levels. Energy boosters are certainly showing signs of growth in all regions tracked by Innova Market Insights. A CAGR in supplement launches of +208.8 percent in South America from 2012 to 2016 is particularly noteworthy, while Europe is top of the pile worldwide with 28.8 percent of its supplement launches having an energy claim in 2016 and its CAGR amounting to a strong +86.7 percent.

Business News

Nutrition 21 launches US media campaign to support Velositol ingredient

11 Dec 2017 --- Nutrition 21, LLC has partnered with NYC-based media relations firm Pitch Publicity and clinical pharmacist James B. LaValle in a national media tour dedicated to educating consumers about the benefits of its proprietary ingredient, Velositol.

Food Ingredients News

Pea stars for Roquette amid alternative protein boom

11 Dec 2017 --- Roquette’s range of pea proteins took a starring role at FiE 2017, and would seem to have a bright future in products promoted by the company. According to the company’s representatives, a key highlight of the company’s newest range of products is around plant-based proteins – many of which are based on pea proteins.

Nutrition & Health News

Soy, cruciferous vegetables linked to fewer breast cancer treatment side effects

11 Dec 2017 --- Consuming soy foods and cruciferous vegetables – such as cabbages, kale, collard greens, bok choy, Brussels sprouts and broccoli – may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, according to a team of scientists led by Georgetown Lombardi Comprehensive Cancer Center. Understanding the role of life style factors with regard to the side effects is important because diet can serve as a modifiable target for possibly reducing symptoms among breast cancer survivors.

Business News

Lakeview Equity invests in nutritional solutions provider NutriScience Innovations

11 Dec 2017 --- Lakeview Equity Partners, LLC, a US$40 million Milwaukee, US-based private equity fund, has invested in NutriScience Innovations, LLC, based in Trumbull, Connecticut, US. NutriScience is a cGMP-certified global supplier of nutritional and functional ingredients to companies that manufacture nutraceutical, pharmaceutical, food and beverage, and dietary products.

More Articles
URL : http://www.nutritioninsight.com:80/news/research-predicts-rise-in-ibd-in-developing-world.html